Introduction
Cytomegalovirus (CMV)' is an important cause of morbidity and mortality in certain patients, particularly transplant recipients and individuals with the acquired immunodeficiency syndrome (AIDS) (1) (2) (3) (4) (5) (6) (7) (8) . Recovery of CMV from peripheral blood leukocytes is relatively common among these patients with reported rates of 30-80% (9) (10) (11) (12) . Viremia is an integral part of the pathogenesis of serious CMV disease in that a sub-stantial percentage of viremic patients develop serious organ injury that may ultimately be fatal (13) (14) (15) (16) .
The interaction of CMV with peripheral blood leukocytes has not been characterized fully. Thus far, studies of separated cell populations using virus culture indicate that most of the infectious virus is associated with polymorphonuclear leukocytes (9, 10, (16) (17) (18) (19) (20) . These findings have been confirmed in one instance by electron microscopy (21) . However, data also exist to suggest that the virus may be carried in lesser amounts or less frequently by mononuclear cells (10, (16) (17) (18) (19) (20) 22) . Advances in molecular hybridization technology have now made it feasible to detect CMV genetic material in peripheral blood leukocytes with viral DNA probes (21, 23, 24) . Using a cloned CMV DNA probe, we have recently completed the initial phase of work in studies ofthe virus-cell interactions involved in CMV viremia. The goal of our investigation has been to identify the type of leukocytes that harbor infectious virus and viral DNA, to determine the quantity of viral genetic material within particular cell populations, and to ascertain whether the results of DNA hybridization and virus culture are correlated in polymorphonuclear and mononuclear leukocytes.
Methods
Patient population. 43 blood specimens were obtained from 25 individuals. 21 ofthe patients had had recent viremia documented by virus culture in the clinical virology laboratory. These included 1 patient with AIDS, and 20 transplant recipients (nine kidney, seven bone marrow, one liver-kidney, one pancreas-kidney, one liver, and one pancreas). Blood was initially obtained within 1-3 d of recovery of CMV in diploid fibroblast cultures. In addition, sequential specimens were obtained from certain individuals. Overall, CMV was recovered by culture in 21 instances in the infectious diseases research laboratory. Of the remaining 22 specimens who did not yield CMV in culture, viremia had been documented within the preceding 2 wk in nine instances and in the preceding 3-7 wk in four instances. On five occasions, leukocytes were also obtained from patients who were treated with 9-(1,3-dihydroxy-2-propoxymethyl)guanine (BW759 or DHPG), an acyclovir analogue that has excellent activity against CMV in vitro (25). Four additional patients were studied at a time when their culture status was not known: one bone marrow transplant recipient with biopsy-proven CMV esophagitis and progressive chorioretinitis, one kidney transplant patient with graft rejection and CMV chorioretinitis, and two febrile patients with leukemia who experienced a fourfold rise in CMV-specific antibody titers. CMV was never recovered from the leukocytes of these four individuals.
Peripheral blood leukocytes were also obtained from 55 healthy blood donors for subsequent DNA hybridization. 25 of these individuals possessed CMV-specific antibody at a minimal dilution of 1:4 as determined by indirect hemagglutination (Cetus Corp., Emeryville, CA) (26). There were 30 donors who were seronegative for CMV.
Collection and separation ofleukocytes. 10-20 ml of heparinized blood was obtained from the patients and volunteers described above. The blood was separated into polymorphonuclear and mononuclear leukocyte fractions by conventional means using Ficoll-Hypaque (27) . A Wright stain preparation of each leukocyte fraction indicated a pu-rity of 97.5±2.2% for the mononuclear cells and 93.8±4.7% for the polymorphonuclear leukocytes. Aliquots of separated cells in suspension were cultured for CMV as outlined below. The remaining polymorphonuclear and mononuclear leukocytes were washed in phosphate-buffered saline, pelleted, and stored at -70'C for subsequent DNA extraction and dot-blot hybridization to detect CMV DNA.
Virus culture. Sequential logrithmic dilutions of polymorphonuclear and mononuclear leukocytes were cultured on human foreskin fibroblast monolayers in duplicate wells. Additional fibroblasts were added to any culture wells, demonstrating significant toxicity during the observation period. Cultures were maintained with minimal essential medium containing 15% fetal calf serum and antibiotics. The medium was changed twice weekly. Cultures were observed for the cytopathic effects of human CMV at least three times weekly for a minimum duration of 4 wk.
Radiolabeled subgenomic probe. For detection of CMV DNA in leukocytes, the Xbal fragment "C" of the Towne strain of human CMV, kindly supplied by Dr. Mark Stinski, University of Iowa, Iowa City, IA, was used as the probe. This fragment is derived from the long unique portion of the viral genome and contains 32 kilobase pairs (kbp), -13.3% of the viral genome (28) . The Xba I fiagment C does not hybridize with cellular DNA, nor with the DNA of other herpes viruses. In addition, these gene sequences are represented in all strains of CMV studied to date.
The fragment was cloned in the plasmid vector pACYC184 in Escherichia Coli strain HB101 (28) . The plasmid was purified by ultracentrifugation to equilibrium in a cesium chloride-ethidium bromide gradient (29) . The final concentrations of the cesium chloride and ethidium bromide were 1.55 g/ml and 600 Mg/ml, respectively. This preparation was then centrifuged at 144,000 g for 36 h at 20'C. The plasmid band was recovered from the centrifuge tube using a 16-gauge needle and freed from ethidium bromide by isoamyl alcohol extraction. The DNA was subsequently dialyzed against 1% phenol, 1 M NaCl in IX Tris EDTA, and twice against IX Tris EDTA. After ethanol precipitation, the plasmid DNA was digested with Xba I endonuclease for 2 h at 37°C. The fragment Xba I C insert was then separated from pACYC184 by electrophoresis on a 0.7% agarose gel with ethidium bromide at a final concentration of0.5 Mg/ml. The DNA was recovered by electroelution. After removal of ethidium bromide, the fragment was dialyzed against water. Final purification ofthe DNA was achieved by passage over an elutip column (Schleicher & Schuell, Keene, NH).
The probe was radiolabeled by nick-translation using [32P-deoxycytidine triphosphate by the methods of Rigby et al. (30) with modification. Briefly, 2.5 U of DNA polymerase I and 50 pg DNase I were added to the reaction mixture containing 0.8 Mug of the Xba I fragment C, 31 pmol of [32P]deoxycytidine triphosphate and the nucleotide buffer solution (dATP, dGTP, and dTTP). After 21/2 h at 15°C, the reaction was terminated with EDTA at a final concentration of 50 mM. The unincorporated counts were separated from the 32P radiolabeled fragment using a Sephadex G-50 column. The probe was stored at -70°C. Before hybridization, 80 ng of the radiolabeled probe was denatured by boiling for 10 min and quickly chilling. The specific activity of the probe in different experiments ranged from 1.5 to 4.0 X 10i cpm/ug of DNA.
Extraction of DNA from leukocyte fractions. DNA was extracted from leukocyte populations using the following methods (29) . Polymorphonuclear and mononuclear cell pellets were resuspended in DNA buffer and incubated overnight at 37°C with RNase (500 ng/ml), SDS (2%), and proteinase K (1.0 mg/ml). The DNA was then extracted twice with phenol in 2% chloroform-isoamyl alcohol, once with 2% chloroform-isoamyl alcohol, and two to three times with water-saturated ethyl ether. The DNA was precipitated with one-tenth volume of 3 M sodium acetate and two vol ofethanol at -70°C. After centrifugation and drying, the DNA was resuspended in water and stored at -700C.
Dot-blot hybridization. The polymorphonuclear or mononuclear leukocyte DNA was denatured in 0. For each blot, similar quantitative controls were prepared, and a new equation (y = mx + b) was derived to quantitate the amount of CMV DNA in patient leukocyte samples. Using this relationship, the amount of CMV DNA (x) in an individual sample was determined once the optical density (y) was known. Samples were considered positive for viral DNA when the optical density exceeded that of the 95% confidence interval for the mean value assigned to leukocyte DNA obtained from an individual seronegative for CMV. The modified video scanning method was far more reliable than visual inspection for detection of small differences in the intensity of autoradiographic signals.
Once the number of picograms of viral DNA present in the leukocyte samples had been determined, the results were expressed as the number of viral genome equivalents based on the following calculations. The CMV genome contains 240 kbp and weighs 1.56 X 108 D (28, 32) . Since 1 D is 1.65 X 10-24 g, the viral genome contains 2. Table I) .
The amount ofCMV DNA detected by dot-blot hybridization in each leukocyte population for viremic patients is also summarized in Table I and presented graphically in Fig. 4 was present in polymorphonuclear cells than in mononuclear leukocytes (13.1 vs. 9.1 viral genome equivalents per 100 cells, respectively; t(lS) = 2.2, P < 0.05). When CMV was recovered from both cell populations, a significantly greater quantity of viral DNA was detected in granulocytes than when the virus was recovered solely from polymorphonuclear leukocytes (15.1 vs. 6.3 viral genome equivalents, respectively; t(l2) = 2.4, P < 0.05) (Table II) . However, the amount of CMV DNA detected in mononuclear cells with positive cultures for CMV was not significantly greater than that detected in culture-negative mononuclear leukocytes. Note that the quantity of viral DNA in each cell population was virtually identical at times when CMV was recovered only from neutrophils (Table II) . Also of note was the finding that polymorphonuclear leukocytes yielding CMV within 14 d in culture contained a significantly greater amount ofviral DNA than cells requiring > 14 d in culture (22 vs. 7 viral genome equivalents per 100 cells, respectively; t(6) = 3.9, P < 0.02). In this regard, no significant difference was found for mononuclear cells. The quantity of CMV DNA present in leukocytes of patients who were not viremic at the time of sampling is also summarized in Table I . Here, the amount of viral DNA was substantially less in both cell populations compared with the samples with positive cultures previously described. However, no statistically significant difference was noted in the amount of CMV DNA detected in polymorphonuclear versus mononuclear leukocytes in the patients with negative cultures.
No viral DNA was detected by dot-blot hybridization in leukocytes obtained from 30 individuals who were seronegative for CMV. Additionally, CMV DNA was not detected in the leukocytes of 25 healthy blood donors with CMV. antibody.
Discussion
The recovery of CMV from peripheral blood leukocytes is a hallmark of disseminated disease, unlike viral shedding in urine or saliva (1, (14) (15) (16) . Hence, viremia has been a major focus of intensive investigation. Most studies of separated cell populations have shown CMV to be associated primarily with polymorphonuclear leukocytes (9, 10, (16) (17) (18) (19) (20) . However, CMV has also been shown to be carried in lesser amounts or less frequently by mononuclear cells (10, (16) (17) (18) (19) (20) 22) . In two studies involving 19 patients, 12 of whom were renal transplant recipients, CMV was recovered from the polymorphonuclear and mononuclear leukocytes in 16 (84%) and 11 (58%), re- * Viremia is defined as the recovery of infectious virus from one or both cell populations on the day that the blood was collected for culture and DNA hybridization. $ Two mononuclear leukocyte samples were lost due to contamination. spectively ( 18, 19) . In one ofthese studies ( 19) , infectious virus was associated solely with granulocytes in 3/7 patients (43%) as opposed to mononuclear leukocytes alone in 1/7 patients (14%). Similarly, Howell et al. recovered CMV from 12/15 (80%) polymorphonuclear and 8/16 (50%) mononuclear leukocyte specimens from viremic patients with leukemia and aplastic anemia before bone marrow transplantation (20) . Here, in 6/16 (38%), CMV was recovered solely from neutrophils as opposed to the mononuclear leukocytes alone in 3/16 (19%). In contrast to these studies, Zaia et al. recovered CMV solely from the mononuclear leukocytes in only 1 of 20 specimens (9) . All cultures of the corresponding polymorphonuclear leukocytes were positive for CMV. Our results are comparable with the majority of these earlier investigations. CMV was virtually always recovered from polymorphonuclear leukocytes, and less frequently associated with mononuclear cells (100 vs. 42%, respectively). In addition, CMV was recovered only from neutrophils in 58%. In no instance was infectious virus recovered solely from mononuclear leukocytes. DNA hybridization has now been used to detect CMV DNA in urine, infected tissues, and human leukocytes in several laboratories (21, 23, (33) (34) (35) (36) (37) (38) However, the results of culture and DNA hybridization were strikingly discordant for mononuclear cells in our studies. Whereas CMV was recovered in culture from only 7/15 (46.6%) mononuclear cell samples, viral DNA was nonetheless detected in 16/17 (94%), a frequency virtually identical to that found in polymorphonuclear cells. Even so, the amount of viral DNA within mononuclear leukocytes was significantly less than in polymorphonuclear cells. The reasons for the differences between culture and hybridization results for mononuclear leukocytes are not clear. The findings cannot be explained on the basis of contamination of mononuclear cell populations with polymorphonuclear leukocytes containing infectious virus. If this were the case, the maximal amount of CMV DNA expected in mononuclear cells would have been -1 viral genomic equivalent per 100 cells rather than the 9. 1 detected (Table I) . Nor does the disparity in hybridization and culture results between the two populations of cells appear to be strictly quantitative. Infectious virus was always recovered from granulocytes of the viremic patients whether the amount of CMV DNA within them was high or low. Yet when the amounts of viral DNA were virtually identical in mononuclear and polymorphonuclear cells collected simultaneously from the same patients, infectious CMV could not be recovered from the mononuclear leukocytes (Table II) . These findings suggest that CMV exists within granulocytes in mature infectious form and are consistent with the single instance in which viral nucleocapsids were visualized within phagocytic vacuoles by electron microscopy (21) . No information is yet available concerning the type(s) of mononuclear cells infected with CMV or the state of the virus within mononuclear cells during viremia. However, note that CMV was recovered primarily from T lymphocytes in one study (22) . Additionally, recent reports based on the use of molecular technology indicate that various types of mononuclear cells can be infected with CMV in vitro, at least with wild-type virus strains (39) (40) (41) . Here, the infection appears to be primarily abortive, in that synthesis and release of infectious progeny virus does not occur. Thus, it is possible that one or more types of mononuclear cells are infected abortively with CMV during viremia, whereas others may occasionally produce infectious virus. We have now initiated studies using in situ nucleic acid hybridization (24, 36) (23) . The greater frequency of detection of viral DNA in our study probably reflects a more highly selected patient population. Here, all but two patients either had recently documented viremia or had other evidence ofdisseminated CMV disease. Under these circumstances, we do not know whether the probe was simply more "'sensitive" than culture for detection of infectious CMV or whether detection of viral DNA reflected the presence of noninfectious incomplete virus within cells. Nevertheless, it is clear from data presented in this report that the ability to detect viral nucleic acid in cells adds a new dimension to the use of virus culture in studies of CMV pathogenesis at the molecular level.
